Ajo LP increased its position in shares of HCA Healthcare Inc (NYSE:HCA) by 49.3% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 340,461 shares of the company’s stock after purchasing an additional 112,361 shares during the quarter. Ajo LP’s holdings in HCA Healthcare were worth $44,389,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vanguard Group Inc boosted its stake in HCA Healthcare by 0.3% in the third quarter. Vanguard Group Inc now owns 19,916,360 shares of the company’s stock valued at $2,770,765,000 after acquiring an additional 66,808 shares in the last quarter. CWM LLC boosted its stake in HCA Healthcare by 157.2% in the fourth quarter. CWM LLC now owns 1,070 shares of the company’s stock valued at $133,000 after acquiring an additional 654 shares in the last quarter. First Manhattan Co. boosted its stake in HCA Healthcare by 21.1% in the fourth quarter. First Manhattan Co. now owns 1,090 shares of the company’s stock valued at $135,000 after acquiring an additional 190 shares in the last quarter. Trust Co. of Vermont boosted its stake in HCA Healthcare by 165.3% in the fourth quarter. Trust Co. of Vermont now owns 329 shares of the company’s stock valued at $41,000 after acquiring an additional 205 shares in the last quarter. Finally, Wedbush Securities Inc. acquired a new position in HCA Healthcare in the fourth quarter valued at $585,000. 70.25% of the stock is owned by institutional investors and hedge funds.

Shares of HCA opened at $123.03 on Tuesday. HCA Healthcare Inc has a fifty-two week low of $101.30 and a fifty-two week high of $147.42. The stock has a market cap of $41.41 billion, a PE ratio of 12.59, a price-to-earnings-growth ratio of 0.97 and a beta of 0.76.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, April 30th. The company reported $2.97 earnings per share for the quarter, topping the consensus estimate of $2.31 by $0.66. HCA Healthcare had a net margin of 7.71% and a negative return on equity of 112.65%. The business had revenue of $12.52 billion during the quarter, compared to the consensus estimate of $12.34 billion. During the same quarter in the prior year, the firm earned $3.18 earnings per share. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. Research analysts expect that HCA Healthcare Inc will post 10.38 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Stockholders of record on Monday, June 3rd will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, May 31st. This represents a $1.60 annualized dividend and a dividend yield of 1.30%. HCA Healthcare’s dividend payout ratio (DPR) is 16.38%.

Several equities analysts have issued reports on the stock. Zacks Investment Research downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price objective for the company. in a research note on Monday, May 27th. Jefferies Financial Group set a $158.00 price objective on shares of HCA Healthcare and gave the company a “buy” rating in a research note on Wednesday, April 17th. ValuEngine downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, March 6th. Barclays decreased their price objective on shares of HCA Healthcare from $155.00 to $145.00 and set an “overweight” rating for the company in a research note on Wednesday, April 17th. Finally, Deutsche Bank upped their price objective on shares of HCA Healthcare from $160.00 to $165.00 and gave the company a “buy” rating in a research note on Wednesday, May 1st. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and eighteen have given a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $149.00.

In other news, insider Jon M. Foster sold 44,281 shares of the stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $122.28, for a total transaction of $5,414,680.68. Following the completion of the sale, the insider now owns 96,052 shares in the company, valued at $11,745,238.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 2.70% of the stock is currently owned by corporate insiders.

WARNING: This news story was first posted by Watch List News and is the property of of Watch List News. If you are accessing this news story on another domain, it was copied illegally and reposted in violation of US & international trademark & copyright laws. The legal version of this news story can be viewed at https://www.watchlistnews.com/hca-healthcare-inc-hca-position-raised-by-ajo-lp/3030824.html.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: Options Trading – Understanding Strike Price

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.